Ânima (ANIM3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jul, 2026Executive summary
Achieved 12 consecutive quarters of margin expansion, with adjusted EBITDA ex-IFRS16 up 17.5% year-over-year to R$1,084.9 million, surpassing R$1 billion for the first time, and completed full integration of Laureate assets and systems.
Enhanced student and educator experience through technology upgrades, improved Ulife app ratings, and new omnichannel support, while receiving top academic recognitions including highest MEC scores and the OAB Recommend Seal.
Welcomed new CEO Paula Harraca, restructured the executive committee, and implemented decentralized marketing strategies to drive the next growth phase.
Inspirali expanded its medical education portfolio, received top Ministry of Education scores, and acquired Eu Médico Residente, boosting CME revenue and student base.
Focused on operational efficiency, student retention, and setting the stage for sustainable growth with a leaner executive structure.
Financial highlights
Net revenue grew 1.8% year-over-year to R$3,801.4 million in 2024; adjusted gross profit rose 4.0% to R$2,557.7 million, with gross margin expanding by 1.4 p.p. to 67.3%.
Adjusted EBITDA ex-IFRS16 increased 17.5% to R$1,084.9 million, with margin up 3.8 p.p. to 28.5%.
Adjusted net income reached R$187.0 million, reversing a R$46.4 million loss in 2023; net income attributable to controlling shareholders was R$85.1 million.
Cash flow to firm rose 10.2% to R$783.6 million; cash position at year-end was R$1,252.0 million (+27.2% YoY).
Leverage (net debt/EBITDA adj. ex-IFRS16) reduced to 2.80x from 3.25x; average debt tenor extended to 4.1 years.
Outlook and guidance
Entering a new growth phase focused on sustainable revenue expansion, with confidence in continued margin expansion, cash generation, and sufficient liquidity to cover debt maturities through 2027.
Ongoing investments in technology, academic quality, and operational efficiency to drive student retention and experience.
Anticipates further growth in medical education with new course authorizations, integration of Eu Médico Residente, and participation in Mais Médicos III.
Plans to launch the first university dedicated to the creator economy in partnership with Agência Califórnia.
Latest events from Ânima
- Revenue and profitability rose across all segments, with improved leverage and cash flow.ANIM3
Q1 20258 Jul 2026 - Net revenue rose 5.8% to R$4.02B, with 11.2% EBITDA growth and 45.3% higher net income.ANIM3
Q4 20258 Jul 2026 - Revenue, EBITDA, and net income rose year-over-year, with margin gains and lower leverage.ANIM3
Q2 20258 Jul 2026 - Revenue, EBITDA, and net income rose sharply in 3Q25, with leverage down to 2.40x.ANIM3
Q3 20258 Jul 2026 - Margin and profit growth, lower leverage, and strong digital and medical segment performance.ANIM3
Q2 20248 Jul 2026 - Net revenue up 7.7% and net income up 11.0%, with improved leverage and strong cash flow.ANIM3
Q1 20268 Jul 2026 - Record margin expansion and cash generation drive lower leverage and improved profitability.ANIM3
Q3 20246 Jul 2026 - AI-driven expansion and disciplined growth are transforming education quality and impact.ANIM3
Investor Day 20253 Feb 2026 - New CEO appointed to drive growth, efficiency, and ESG focus after structured succession.ANIM3
Status Update3 Feb 2026